MedTrace Logo

Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression

NCT03329287 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2017-11-01

No results posted yet for this study

Summary

This trial attempts to evaluate the treatment efficacy of Simplified Cognitive Behavioral Therapy (SCBT) and its safety among schizophrenia patients. Half of participants will be randomized to accept SCBT.

Conditions

Interventions

BEHAVIORAL

SCBT

SCBT, one hour per session.

DRUG

SSRIs and/or SNRIs

SSRIs and/or SNRIs at a recommended dosage.

BEHAVIORAL

Psychological Placebo

Supportive and relaxation therapy, one our per session.

Sponsors & Collaborators

  • Changhai Hospital

    collaborator OTHER

  • Shanghai 10th People's Hospital

    collaborator OTHER

  • Tongji Hospital

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • Second Hospital of Shanxi Medical University

    collaborator OTHER

  • Shanghai Mental Health Center

    lead OTHER

Principal Investigators

  • Chunbo Li, PHD · Shanghai Mental Health Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-03-30
Completion
2018-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03329287 on ClinicalTrials.gov